 |
市場調查報告書
商品編碼
1794016
全球橫向流動化驗市場（按產品、應用、方法、樣本類型、最終用戶和地區分類）- 預測至 2030 年Lateral Flow Assays Market by Product, Application, Sample, Technique, End User, and Region - Global Forecast to 2030 |
||||||
價格
預計橫向流動化驗市場將從 2025 年的 85.1 億美元成長到 2030 年的 125.2 億美元，預測期內的複合年成長率為 8.0%。
| 調查範圍 | |
|---|---|
| 調查年份 | 2024-2030 |
| 基準年 | 2024 |
| 預測期 | 2025-2030 |
| 對價單位 | 金額（十億美元） |
| 部分 | 按產品、應用、方法、樣品類型、最終用戶、地區 |
| 目標區域 | 北美、歐洲、亞太地區、拉丁美洲、中東和非洲、海灣合作理事會國家 |
推動該市場成長的關鍵因素包括全球感染疾病的高發性和隨之而來的檢測需求、老年人口的快速成長、家用橫向流動化驗設備的普及以及即時檢測（POC）需求的不斷成長。然而，與其他方法相比，橫向流動化驗市場的成長。
臨床檢測是橫向流動化驗市場中最大的應用領域。根據應用，橫向流動化驗市場可細分為臨床檢測、動物診斷、食品安全和環境檢測以及藥物開發和品質檢測。 2024年，臨床檢測佔據了橫向流動化驗市場的最大佔有率，預計這一趨勢將在本研究期間持續下去。該應用領域的巨大佔有率可以歸因於全球慢性病和感染疾病病率的上升、老年人口的成長、患者對快速檢測方案認知的提高、降低醫療成本的壓力不斷增加以及對以患者為中心的醫療服務日益成長的需求。
根據最終用戶，橫向流動化驗市場細分為醫院和診所、診斷實驗室、居家照護機構、製藥和生物技術公司以及其他。預計到2024年，醫院和診所將佔據最大的市場佔有率。技術進步、就地檢驗的普及率不斷提高以及對快速早期診斷的日益偏好，正在推動醫院和診所市場的成長。
全球橫向流動化驗市場主要分為六大區域：北美、歐洲、亞太、拉丁美洲、中東和非洲、海灣合作理事會國家。北美憑藉其先進的醫療基礎設施、高昂的醫療支出以及主要製造商的佈局，在該市場佔據主導地位。人口老化加劇、感染疾病和慢性病盛行率上升以及對家用和自測檢測套組的強勁需求，檢測套組推動了北美市場的成長。預計該區域市場將在整個預測期內保持主導地位。
本報告研究了全球橫向流動化驗市場，提供了有關產品、應用、方法、樣本類型、最終用戶和地區的市場見解，以及參與市場的公司概況。
目錄
第1章 引言
第2章調查方法
第3章執行摘要
第4章重要考察
第5章市場概述
- 介紹
- 市場動態
- 技術分析
- 波特五力分析
- 監管狀況
- 專利分析
- 貿易分析
- 定價分析
- 大型會議及活動
- 主要相關人員和採購標準
- 橫向流動化驗市場中未滿足的需求/最終用戶的期望
- 價值鏈分析
- 供應鏈分析
- 人工智慧對橫向流動化驗市場的影響
- 生態系分析
- 案例研究分析
- 橫向流動化驗的鄰近市場
- 影響客戶業務的趨勢/中斷
- 投資金籌措場景
- 美國關稅法規對橫向流動化驗市場的影響
第6章橫向流動化驗市場（依產品）
- 介紹
- 套件和試劑
- 領導者
第7章橫向流動化驗市場（按應用）
- 介紹
- 臨床試驗
- 動物診斷
- 食品安全與環境檢測
- 藥物開發和品質測試
第 8 章橫向流動化驗市場（按技術）
- 介紹
- 夾心試驗
- 競爭分析
- 多重檢測分析
第9章橫向流動化驗市場（依樣本類型）
- 介紹
- 血液樣本
- 尿液樣本
- 唾液樣本
- 其他
第 10 章橫向流動化驗市場（依最終使用者）
- 介紹
- 醫院、診所
- 居家照護
- 診斷實驗室
- 製藥和生物技術公司
- 其他
第 11 章橫向流動化驗市場（按地區）
- 介紹
- 北美洲
- 北美宏觀經濟展望
- 美國
- 加拿大
- 歐洲
- 歐洲宏觀經濟展望
- 德國
- 英國
- 法國
- 義大利
- 西班牙
- 其他
- 亞太地區
- 亞太宏觀經濟展望
- 日本
- 中國
- 印度
- 澳洲
- 韓國
- 其他
- 拉丁美洲
- 拉丁美洲宏觀經濟展望
- 巴西
- 墨西哥
- 阿根廷
- 其他
- 中東和非洲
- 海灣合作理事會國家
- 對快速且經濟高效的診斷的需求不斷成長，推動著市場
第12章競爭格局
- 介紹
- 主要參與企業的策略/優勢
- 2020-2024年收益分析
- 2024年市場佔有率分析
- 估值和財務指標
- 品牌/產品比較
- 公司估值矩陣：2024 年關鍵參與企業
- 公司估值矩陣：Start-Ups/中小企業，2024 年
- 競爭場景
第13章：公司簡介
- 主要參與企業
- ABBOTT LABORATORIES
- F. HOFFMANN-LA ROCHE LTD.
- DANAHER CORPORATION
- QUIDELORTHOORTHO CORPORATION
- SIEMENS AG
- BECTON, DICKINSON AND COMPANY
- BIOMERIEUX SA
- THERMO FISHER SCIENTIFIC INC.
- REVVITY, INC.
- QIAGEN NV
- MERCK KGAA
- HOLOGIC, INC.
- SURMODICS, INC.
- ORASURE TECHNOLOGIES
- 其他公司
- CHEMBIO DIAGNOSTICS INC.
- DCN DIAGNOSTICS
- POLYSCIENCES INC.
- ABINGDON HEALTH
- ORANOXIS INC.
- AESKU.GROUP GMBH
- BIO GROUP MEDICAL SYSTEM SRL
- PHARMACT GMBH
- XIAMEN BIOTIME BIOTECHNOLOGY CO., LTD.
- BIOPANDA REAGENTS LTD
- ARTRON LABORATORIES INC.
第14章 附錄
Product Code: MD 4158
The lateral flow assays market is estimated to grow from USD 8.51 billion in 2025 to USD 12.52 billion by 2030 at a CAGR of 8.0%, during the forecast period.
| Scope of the Report | |
|---|---|
| Years Considered for the Study | 2024-2030 |
| Base Year | 2024 |
| Forecast Period | 2025-2030 |
| Units Considered | Value (USD billion) |
| Segments | Product, Application, Technique, Sample Type, and End User |
| Regions covered | North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC Countries |
This is due to the high prevalence of infectious diseases worldwide and the subsequent need for testing, rapid growth in the geriatric population, the rising use of home-based lateral flow assay devices, and the growing demand for POC testing, which are the major factors driving the growth of this market. However, inconsistent accuracy compared to other methods and the reluctance of doctors and patients to shift from traditional diagnostics restrain the growth of the lateral flow assays market.
"The clinical testing segment of the lateral flow assays market, by application, is estimated to hold the largest position during the forecast period."
The clinical testing segment is the largest application segment in the lateral flow assays market. Based on applications, the lateral flow assays market is segmented into clinical testing, veterinary diagnostics, food safety & environmental testing, and drug development & quality testing. The clinical testing segment accounted for the largest share of the lateral flow assays market in 2024. This trend is projected to continue during the study period. The large share of this application segment can be attributed to the rising prevalence of chronic diseases and infectious diseases worldwide, the growing geriatric population, increasing patient awareness about rapid test options, the growing pressure to reduce healthcare costs, and the increasing demand for patient-centric care.
"The hospitals & clinics segment accounted for the largest market share in the lateral flow assays market."
Based on end users, the LFA market is segmented into hospitals & clinics, diagnostic laboratories, home care settings, pharmaceutical & biotechnology companies, and others. The hospitals and clinics segment accounted for the largest market share in 2024. Technological advancements, increasing adoption of point-of-care testing, and the growing inclination toward fast and early diagnosis are driving the growth of the hospitals & clinics segment.
"North America segment of the lateral flow assays market, by region, is estimated to account for the largest share during the forecast period."
The global lateral flow assays market is segmented into six major regions: North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC Countries. North America holds the leading position in this market, driven by advanced healthcare infrastructure, significant healthcare expenditure, and the strong presence of key manufacturers. The increasing aging population, rising prevalence of infectious and chronic diseases, and strong demand for home-use and self-test kits further support market growth in North America. This regional segment is expected to maintain its dominant position throughout the forecast period.
A breakdown of the primary participants referred to for this report is provided below:
- By Company Type: Tier 1: 40%, Tier 2: 30%, and Tier 3: 35%
- By Designation: C Level: 27%, Director Level: 18%, and Others: 55%
- By Region: North America: 50%, Europe: 20%, Asia Pacific: 20%, Latin America: 7%, and Middle East & Africa: 3%
Note 1: Companies are classified into tiers based on their total revenue. As of 2024, Tier 1 = Greater than USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = Less than USD 1.00 billion.
Note 2: C-level primaries include CEOs, CFOs, COOs, and VPs.
Note 3: Other designations include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
The major players operating in the lateral flow assays market are Abbott Laboratories (US), F. Hoffman-La Roche Ltd. (Switzerland), Danaher Corporation (US), Becton, Dickinson and Company (US), QuidelOrtho Corporation (US), Siemens AG (Germany), bioMerieux SA (France), Thermo Fisher Scientific, Inc. (US), Revvity, Inc. (US), Hologic Inc. (US), QIAGEN N.V. (Netherlands), Merck KGaA (Germany), Surmodics, Inc. (US), and OraSure Technologies Inc. (US).
Research Coverage
This report studies the lateral flow assays market based on product, application, technique, sample type, end user, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends. It forecasts the revenue of the market segments with respect to six major regions (and the respective countries in these regions).
Reasons to Buy the Report
The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to gain a larger market share. Firms purchasing the report could use one or a combination of the strategies mentioned below to strengthen their market presence.
This report provides insights on the following points:
- Analysis of key drivers (High prevalence of infectious diseases, Rising geriatric population, Growing use of home-based lateral flow assay devices, and Growing demand for POC testing), restraints (Inconsistent results of lateral flow assay tests), opportunities (Evolving applications of lateral flow assays and Rising demand for lateral flow assays in food & beverage industry), challenges (Limited reimbursements for lateral flow assay products and Difficulties in procuring quality raw materials to develop tests).
- Market Penetration: Comprehensive information on the product portfolios offered by the top players in the lateral flow assays market
- Product Development/Innovation: Detailed insights into the upcoming trends, R&D activities, and product launches in the lateral flow assays market
- Market Development: Comprehensive information on lucrative emerging regions
- Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the lateral flow assays market
- Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players
TABLE OF CONTENTS
1 INTRODUCTION
- 1.1 STUDY OBJECTIVES
- 1.2 MARKET DEFINITION
- 1.2.1 INCLUSIONS & EXCLUSIONS
- 1.3 MARKET SCOPE
- 1.3.1 MARKETS COVERED
- 1.3.2 YEARS CONSIDERED
- 1.4 CURRENCY CONSIDERED
- 1.5 STAKEHOLDERS
- 1.6 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
- 2.1 RESEARCH DATA
- 2.1.1 SECONDARY DATA
- 2.1.1.1 Key data from secondary sources
- 2.1.2 PRIMARY DATA
- 2.1.2.1 Primary sources
- 2.1.2.2 Key industry insights
- 2.1.2.3 Key data from primary sources
- 2.1.2.4 Breakdown of primary interviews
- 2.1.1 SECONDARY DATA
- 2.2 MARKET SIZE ESTIMATION
- 2.2.1 BOTTOM-UP APPROACH
- 2.2.1.1 Approach 1: Company revenue estimation approach
- 2.2.1.2 Approach 2: Presentations of companies and primary interviews
- 2.2.1.3 Approach 3: Primary interviews
- 2.2.1.4 Approach 4: Growth Forecast
- 2.2.1.5 CAGR projections
- 2.2.2 TOP-DOWN APPROACH
- 2.2.1 BOTTOM-UP APPROACH
- 2.3 MARKET BREAKDOWN & DATA TRIANGULATION
- 2.4 RESEARCH ASSUMPTIONS
- 2.4.1 STUDY-RELATED ASSUMPTIONS
- 2.4.2 GROWTH RATE ASSUMPTIONS
- 2.5 RISK ASSESSMENT
- 2.6 RESEARCH LIMITATIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
- 4.1 LATERAL FLOW ASSAYS MARKET OVERVIEW
- 4.2 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET, BY APPLICATION AND COUNTRY
- 4.3 LATERAL FLOW ASSAYS MARKET, BY COUNTRY
- 4.4 LATERAL FLOW ASSAYS MARKET: REGIONAL MIX
- 4.5 LATERAL FLOW ASSAYS MARKET: EMERGING ECONOMIES VS. DEVELOPED MARKETS
5 MARKET OVERVIEW
- 5.1 INTRODUCTION
- 5.2 MARKET DYNAMICS
- 5.2.1 DRIVERS
- 5.2.1.1 High prevalence of infectious diseases
- 5.2.1.2 Rise in geriatric population
- 5.2.1.3 Growing use of home-based lateral flow assay devices
- 5.2.1.4 Growth in demand for POC testing
- 5.2.2 RESTRAINTS
- 5.2.2.1 Inconsistent results of lateral flow assays
- 5.2.3 OPPORTUNITIES
- 5.2.3.1 Evolving applications of lateral flow assays
- 5.2.3.2 Rise in demand for lateral flow assays in food & beverage industry
- 5.2.4 CHALLENGES
- 5.2.4.1 Limited reimbursements for lateral flow assay products
- 5.2.4.2 Difficulties in procuring quality raw materials to develop tests
- 5.2.1 DRIVERS
- 5.3 TECHNOLOGY ANALYSIS
- 5.3.1 KEY TECHNOLOGIES
- 5.3.1.1 Immunochromatography
- 5.3.2 COMPLEMENTARY TECHNOLOGIES
- 5.3.2.1 Lyophilization (Freeze-drying) Technologies
- 5.3.3 ADJACENT TECHNOLOGIES
- 5.3.3.1 ELISA (ENZYME-LINKED IMMUNOSORBENT ASSAYS)
- 5.3.1 KEY TECHNOLOGIES
- 5.4 PORTER'S FIVE FORCES ANALYSIS
- 5.4.1 BARGAINING POWER OF SUPPLIERS
- 5.4.2 BARGAINING POWER OF BUYERS
- 5.4.3 THREAT OF NEW ENTRANTS
- 5.4.4 THREAT OF SUBSTITUTES
- 5.4.5 INTENSITY OF COMPETITIVE RIVALRY
- 5.5 REGULATORY LANDSCAPE
- 5.5.1 REGULATORY ANALYSIS
- 5.5.1.1 North America
- 5.5.1.2 Europe
- 5.5.1.3 Asia Pacific
- 5.5.1.3.1 India
- 5.5.1.3.2 China
- 5.5.1.3.3 Japan
- 5.5.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- 5.5.2.1 North America
- 5.5.2.2 Europe
- 5.5.2.3 Asia Pacific
- 5.5.2.4 Latin America
- 5.5.2.5 Rest of the world
- 5.5.1 REGULATORY ANALYSIS
- 5.6 PATENT ANALYSIS
- 5.7 TRADE ANALYSIS
- 5.7.1 IMPORT DATA (HS CODE 382200)
- 5.7.2 EXPORT DATA (HS CODE 382200)
- 5.8 PRICING ANALYSIS
- 5.8.1 INDICATIVE AVERAGE SELLING PRICE TREND, BY REGION
- 5.9 KEY CONFERENCES AND EVENTS
- 5.10 KEY STAKEHOLDERS AND BUYING CRITERIA
- 5.10.1 KEY STAKEHOLDERS IN BUYING PROCESS
- 5.10.2 BUYING CRITERIA
- 5.11 UNMET NEEDS/END-USER EXPECTATIONS IN LATERAL FLOW ASSAYS MARKET
- 5.12 VALUE CHAIN ANALYSIS
- 5.13 SUPPLY CHAIN ANALYSIS
- 5.14 IMPACT OF AI ON LATERAL FLOW ASSAYS MARKET
- 5.14.1 INTRODUCTION
- 5.14.2 MARKET POTENTIAL OF AI IN LATERAL FLOW ASSAYS MARKET
- 5.14.3 AI USE CASES
- 5.14.4 KEY COMPANIES IMPLEMENTING AI
- 5.14.5 FUTURE OF AI IN LATERAL FLOW ASSAYS MARKET
- 5.15 ECOSYSTEM ANALYSIS
- 5.16 CASE STUDY ANALYSIS
- 5.16.1 QUIDEL LAUNCHED NEW TEST WITH BROADER DETECTION WINDOW
- 5.16.2 ABINGTON OFFERED HIGH-SENSITIVITY TESTS FOR GREATER QUALITY
- 5.16.3 SIEMENS OFFERS HIGH-SENSITIVITY TROPONIN I ASSAY TO RAPIDLY DETECT ACUTE MYOCARDIAL INFARCTION
- 5.17 ADJACENT MARKETS FOR LATERAL FLOW ASSAYS MARKET
- 5.18 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
- 5.19 INVESTMENT AND FUNDING SCENARIO
- 5.20 IMPACT OF US TARIFF REGULATION ON LATERAL FLOW ASSAYS MARKET
- 5.20.1 INTRODUCTION
- 5.20.2 KEY TARIFF RATES
- 5.20.3 PRICE IMPACT ANALYSIS
- 5.20.4 KEY IMPACTS ON COUNTRY/REGION
- 5.20.4.1 North America
- 5.20.4.2 Europe
- 5.20.4.3 Asia Pacific
- 5.20.5 IMPACT ON END-USE INDUSTRIES
- 5.20.5.1 Hospitals and Clinics
6 LATERAL FLOW ASSAYS MARKET, BY PRODUCT
- 6.1 INTRODUCTION
- 6.2 KITS & REAGENTS
- 6.2.1 RISE IN DEMAND FOR POC TESTING TO DRIVE MARKET
- 6.3 READERS
- 6.3.1 DIGITAL/HANDHELD READERS
- 6.3.1.1 Technological evolution and demand for accuracy to drive adoption
- 6.3.2 BENCHTOP READERS
- 6.3.2.1 Lower diagnosis cost per patient to drive segment
- 6.3.1 DIGITAL/HANDHELD READERS
7 LATERAL FLOW ASSAYS MARKET, BY APPLICATION
- 7.1 INTRODUCTION
- 7.2 CLINICAL TESTING
- 7.2.1 INFECTIOUS DISEASE TESTING
- 7.2.1.1 Mosquito-borne diseases
- 7.2.1.1.1 Increase in incidence of dengue and introduction of more reliable test kits to drive market
- 7.2.1.2 Influenza
- 7.2.1.2.1 Rise in prevalence of influenza globally to boost market growth, despite lower sensitivity of lateral flow assays
- 7.2.1.3 Sexually transmitted infections
- 7.2.1.3.1 HIV
- 7.2.1.3.1.1 Growing need for early detection and awareness of HIV POC testing to drive market
- 7.2.1.3.2 HPV
- 7.2.1.3.2.1 Rapid HPV diagnostics and real-time PCR, covering broad range of genotypes, coupled with higher incidence of cervical cancer to drive segment
- 7.2.1.3.3 Chlamydia
- 7.2.1.3.3.1 Greater viability of advanced techniques to drive market
- 7.2.1.3.4 Gonorrhea
- 7.2.1.3.4.1 Rising incidence of gonorrhea and antimicrobial resistance to augment growth
- 7.2.1.3.5 Syphilis
- 7.2.1.3.5.1 Need for early and accessible diagnosis to fuel growth
- 7.2.1.3.6 Other sexually transmitted infections
- 7.2.1.3.1 HIV
- 7.2.1.4 Hepatitis
- 7.2.1.4.1 Nucleic acid hybridization-based LFAs to show strong potential in hepatitis testing
- 7.2.1.5 Tuberculosis
- 7.2.1.5.1 Rise in prevalence and growing focus on early diagnosis and treatment to propel market
- 7.2.1.6 Other infectious diseases
- 7.2.1.1 Mosquito-borne diseases
- 7.2.2 CARDIAC MARKER TESTING
- 7.2.2.1 Troponin I & T
- 7.2.2.1.1 Introduction of high-sensitivity troponin assays to support market growth
- 7.2.2.2 CK-MB
- 7.2.2.2.1 Growing applications of lateral flow tests in acute myocardial injuries to drive market
- 7.2.2.3 BNP & NT-proBNP
- 7.2.2.3.1 Increase in demand for cardiac biomarker tests to detect heart stress and damage to support growth
- 7.2.2.4 Myoglobin
- 7.2.2.4.1 Availability of new high-sensitivity cardiac troponin assays to restrict market growth
- 7.2.2.5 D-Dimer
- 7.2.2.5.1 Rising incidence of CVDs to drive market for D-dimer tests
- 7.2.2.6 Other cardiac marker testing
- 7.2.2.1 Troponin I & T
- 7.2.3 PREGNANCY & FERTILITY TESTING
- 7.2.3.1 Pregnancy testing
- 7.2.3.1.1 Pregnancy testing to hold larger market share but register slower growth
- 7.2.3.2 Fertility testing
- 7.2.3.2.1 Rise in infertility rates to drive demand for POC fertility testing kits
- 7.2.3.1 Pregnancy testing
- 7.2.4 CHOLESTEROL/LIPID TESTING
- 7.2.4.1 Lifestyle changes, cardiovascular disorder incidence to drive segment
- 7.2.5 DRUGS-OF-ABUSE TESTING
- 7.2.5.1 Technological advancements and rising focus on workplace drug testing to drive market
- 7.2.6 OTHER CLINICAL TESTS
- 7.2.1 INFECTIOUS DISEASE TESTING
- 7.3 VETERINARY DIAGNOSTICS
- 7.3.1 INFECTIOUS DISEASE OUTBREAKS AND TESTS AVAILABLE FOR DIFFERENT SPECIES TO DRIVE FRAGMENTED MARKET
- 7.4 FOOD SAFETY & ENVIRONMENT TESTING
- 7.4.1 HIGH SENSITIVITY AND EASE OF USE TO BOOST DEMAND FOR ASSAYS TO CLEAR FOODS FOR MARKET AVAILABILITY
- 7.5 DRUG DEVELOPMENT & QUALITY TESTING
- 7.5.1 GREATER FOCUS ON PRODUCT SAFETY AND QUALITY ASSURANCE TO SUPPORT MARKET GROWTH
8 LATERAL FLOW ASSAYS MARKET, BY TECHNIQUE
- 8.1 INTRODUCTION
- 8.2 SANDWICH ASSAYS
- 8.2.1 WIDE RANGE OF APPLICATIONS IN CLINICAL TESTING TO SUPPORT MARKET GROWTH
- 8.3 COMPETITIVE ASSAYS
- 8.3.1 REDUCED SELECTIVITY AND SENSITIVITY COMPARED TO SANDWICH ASSAYS TO HAMPER GROWTH
- 8.4 MULTIPLEX DETECTION ASSAYS
- 8.4.1 HIGHER ADOPTION OF MULTI-ANALYTE ASSAYS AMONG CLINICIANS TO FUEL MARKET
9 LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE
- 9.1 INTRODUCTION
- 9.2 BLOOD SAMPLES
- 9.2.1 SIGNIFICANT USE OF BLOOD SAMPLES FOR INFECTIOUS DISEASE TESTING TO DRIVE MARKET
- 9.3 URINE SAMPLES
- 9.3.1 GROWING USE OF URINE SAMPLES FOR PREGNANCY AND DRUGS-OF-ABUSE TESTING TO DRIVE MARKET
- 9.4 SALIVA SAMPLES
- 9.4.1 EASY AND LOW-COST COLLECTION, TRANSPORT, AND ANALYSIS OF SALIVA SAMPLES TO SUPPORT ADOPTION
- 9.5 OTHER SAMPLES
10 LATERAL FLOW ASSAYS MARKET, BY END USER
- 10.1 INTRODUCTION
- 10.2 HOSPITALS & CLINICS
- 10.2.1 HIGH DEMAND FOR DIAGNOSTICS ACROSS LARGE POOLS OF PATIENTS IN HOSPITALS TO DRIVE MARKET
- 10.3 HOME CARE SETTINGS
- 10.3.1 GROWING ACCEPTANCE OF REMOTE MONITORING TO PROPEL MARKET
- 10.4 DIAGNOSTIC LABORATORIES
- 10.4.1 LABORATORY TESTING LARGELY PREFERRED OVER PROFESSIONAL SETTINGS FOR URINE AND BLOOD TESTING
- 10.5 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
- 10.5.1 INCREASE IN FOCUS ON PRODUCT SAFETY TO DRIVE ADOPTION OF LATERAL FLOW ASSAYS
- 10.6 OTHER END USERS
11 LATERAL FLOW ASSAYS MARKET, BY REGION
- 11.1 INTRODUCTION
- 11.2 NORTH AMERICA
- 11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
- 11.2.2 US
- 11.2.2.1 Large patient base to drive market growth
- 11.2.3 CANADA
- 11.2.3.1 Availability of research funding and implementation of favorable government initiatives to drive market
- 11.3 EUROPE
- 11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
- 11.3.2 GERMANY
- 11.3.2.1 Well-developed healthcare system and rise in geriatric population to fuel growth
- 11.3.3 UK
- 11.3.3.1 Growth in incidence of chronic conditions to propel market growth
- 11.3.4 FRANCE
- 11.3.4.1 High prevalence of age-related chronic diseases and infectious diseases to drive market
- 11.3.5 ITALY
- 11.3.5.1 Growth in initiatives toward decentralization of medical services to support market growth
- 11.3.6 SPAIN
- 11.3.6.1 Aging population and strong healthcare infrastructure to drive market
- 11.3.7 REST OF EUROPE
- 11.4 ASIA PACIFIC
- 11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
- 11.4.2 JAPAN
- 11.4.2.1 Growing elderly population and well-developed healthcare system to drive market
- 11.4.3 CHINA
- 11.4.3.1 Modernized healthcare system to drive market
- 11.4.4 INDIA
- 11.4.4.1 Growth in healthcare concerns and rise in income levels to propel market growth, despite lack of reimbursement and insurance coverage for lateral flow assay products
- 11.4.5 AUSTRALIA
- 11.4.5.1 Rise in prevalence of infectious disease and healthcare expenditure to support growth
- 11.4.6 SOUTH KOREA
- 11.4.6.1 Growth in healthcare infrastructure to drive market
- 11.4.7 REST OF ASIA PACIFIC
- 11.5 LATIN AMERICA
- 11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
- 11.5.2 BRAZIL
- 11.5.2.1 High private healthcare expenditure and rise in geriatric population to drive market
- 11.5.3 MEXICO
- 11.5.3.1 Increase in demand for advanced medical equipment to drive market
- 11.5.4 ARGENTINA
- 11.5.4.1 Availability of health insurance to favor market growth
- 11.5.5 REST OF LATIN AMERICA
- 11.6 MIDDLE EAST & AFRICA
- 11.7 GCC COUNTRIES
- 11.7.1 RISE IN DEMAND FOR RAPID AND COST-EFFECTIVE DIAGNOSTICS TO DRIVE MARKET
12 COMPETITIVE LANDSCAPE
- 12.1 INTRODUCTION
- 12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
- 12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN LATERAL FLOW ASSAYS MARKET
- 12.3 REVENUE ANALYSIS, 2020-2024
- 12.4 MARKET SHARE ANALYSIS, 2024
- 12.5 COMPANY VALUATION AND FINANCIAL METRICS
- 12.6 BRAND/PRODUCT COMPARISON
- 12.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
- 12.7.1 STARS
- 12.7.2 EMERGING LEADERS
- 12.7.3 PERVASIVE PLAYERS
- 12.7.4 PARTICIPANTS
- 12.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
- 12.7.5.1 Company footprint
- 12.7.5.2 Regional Footprint
- 12.7.5.3 Product Footprint
- 12.7.5.4 Technique Footprint
- 12.7.5.5 Application Footprint
- 12.7.5.6 Sample type Footprint
- 12.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
- 12.8.1 PROGRESSIVE COMPANIES
- 12.8.2 RESPONSIVE COMPANIES
- 12.8.3 DYNAMIC COMPANIES
- 12.8.4 STARTING BLOCKS
- 12.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
- 12.8.5.1 Detailed list of key startup/SME players
- 12.8.5.2 Competitive benchmarking of key startups/SMEs
- 12.9 COMPETITIVE SCENARIO
- 12.9.1 PRODUCT LAUNCHES
- 12.9.2 DEALS
- 12.9.3 EXPANSIONS
13 COMPANY PROFILES
- 13.1 KEY PLAYERS
- 13.1.1 ABBOTT LABORATORIES
- 13.1.1.1 Business overview
- 13.1.1.2 Products offered
- 13.1.1.3 Recent developments
- 13.1.1.3.1 Product launches & approvals
- 13.1.1.4 MnM view
- 13.1.1.4.1 Right to win
- 13.1.1.4.2 Strategic choices
- 13.1.1.4.3 Weaknesses and competitive threats
- 13.1.2 F. HOFFMANN-LA ROCHE LTD.
- 13.1.2.1 Business overview
- 13.1.2.2 Products offered
- 13.1.2.3 MnM view
- 13.1.2.3.1 Right to win
- 13.1.2.3.2 Strategic choices
- 13.1.2.3.3 Weaknesses and competitive threats
- 13.1.3 DANAHER CORPORATION
- 13.1.3.1 Business overview
- 13.1.3.2 Products offered
- 13.1.3.3 MnM view
- 13.1.3.3.1 Right to win
- 13.1.3.3.2 Strategic choices
- 13.1.3.3.3 Weaknesses and competitive threats
- 13.1.4 QUIDELORTHOORTHO CORPORATION
- 13.1.4.1 Business overview
- 13.1.4.2 Products offered
- 13.1.4.3 Recent developments
- 13.1.4.3.1 Deals
- 13.1.5 SIEMENS AG
- 13.1.5.1 Business overview
- 13.1.5.2 Products offered
- 13.1.6 BECTON, DICKINSON AND COMPANY
- 13.1.6.1 Business overview
- 13.1.6.2 Products offered
- 13.1.7 BIOMERIEUX SA
- 13.1.7.1 Business overview
- 13.1.7.2 Products offered
- 13.1.7.3 Recent developments
- 13.1.7.3.1 Deals
- 13.1.8 THERMO FISHER SCIENTIFIC INC.
- 13.1.8.1 Business overview
- 13.1.8.2 Products offered
- 13.1.9 REVVITY, INC.
- 13.1.9.1 Business overview
- 13.1.9.2 Products offered
- 13.1.10 QIAGEN N.V.
- 13.1.10.1 Business overview
- 13.1.10.2 Products offered
- 13.1.11 MERCK KGAA
- 13.1.11.1 Business overview
- 13.1.11.2 Products offered
- 13.1.11.3 Recent developments
- 13.1.11.3.1 Expansions
- 13.1.12 HOLOGIC, INC.
- 13.1.12.1 Business overview
- 13.1.12.2 Products offered
- 13.1.12.3 Recent developments
- 13.1.12.3.1 Deals
- 13.1.13 SURMODICS, INC.
- 13.1.13.1 Business overview
- 13.1.13.2 Products offered
- 13.1.13.3 Recent developments
- 13.1.13.3.1 Deals
- 13.1.14 ORASURE TECHNOLOGIES
- 13.1.14.1 Business overview
- 13.1.14.2 Products offered
- 13.1.1 ABBOTT LABORATORIES
- 13.2 OTHER PLAYERS
- 13.2.1 CHEMBIO DIAGNOSTICS INC.
- 13.2.2 DCN DIAGNOSTICS
- 13.2.3 POLYSCIENCES INC.
- 13.2.4 ABINGDON HEALTH
- 13.2.5 ORANOXIS INC.
- 13.2.6 AESKU.GROUP GMBH
- 13.2.7 BIO GROUP MEDICAL SYSTEM S.R.L
- 13.2.8 PHARMACT GMBH
- 13.2.9 XIAMEN BIOTIME BIOTECHNOLOGY CO., LTD.
- 13.2.10 BIOPANDA REAGENTS LTD
- 13.2.11 ARTRON LABORATORIES INC.
14 APPENDIX
- 14.1 DISCUSSION GUIDE
- 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
- 14.3 CUSTOMIZATION OPTIONS
- 14.4 RELATED REPORTS
- 14.5 AUTHOR DETAILS
List of Tables
- TABLE 1 LATERAL FLOW ASSAYS MARKET: INCLUSIONS & EXCLUSIONS
- TABLE 2 KEY DATA FROM PRIMARY SOURCES
- TABLE 3 LATERAL FLOW ASSAYS MARKET: RISK ASSESSMENT
- TABLE 4 REAL INCIDENCE OF HIV, 2023 (MILLION PEOPLE)
- TABLE 5 POPULATION AGES 65 AND ABOVE (% OF TOTAL POPULATION), 2023
- TABLE 6 LIST OF COMMERCIALLY AVAILABLE SALIVA LFA PRODUCTS
- TABLE 7 LATERAL FLOW ASSAYS MARKET: PORTER'S FIVE FORCES ANALYSIS
- TABLE 8 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 9 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 10 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 11 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 12 ROW: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 13 LATERAL FLOW ASSAYS MARKET: INNOVATIONS AND PATENT REGISTRATIONS, 2023-2025
- TABLE 14 IMPORT DATA (HS CODE 382200), BY COUNTRY, 2020-2024 (USD MILLION)
- TABLE 15 EXPORT DATA (HS CODE 382200), BY COUNTRY, 2020-2024 (USD MILLION)
- TABLE 16 AVERAGE SELLING PRICE OF LATERAL FLOW ASSAYS (KITS & REAGENTS), BY COMPANY, 2023-2025 (USD)
- TABLE 17 AVERAGE SELLING PRICE OF LATERAL FLOW ASSAYS (KITS & REAGENTS), BY APPLICATION, 2023-2025 (USD)
- TABLE 18 INDICATIVE AVERAGE SELLING PRICE OF LATERAL FLOW ANALYZERS, BY REGION, 2023 VS. 2024
- TABLE 19 LATERAL FLOW ASSAYS MARKET: KEY CONFERENCES AND EVENTS, JUNE 2025-DECEMBER 2026
- TABLE 20 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS
- TABLE 21 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS
- TABLE 22 UNMET NEEDS/END-USER EXPECTATIONS IN LATERAL FLOW ASSAYS MARKET
- TABLE 23 LATERAL FLOW ASSAYS MARKET: ROLE OF COMPANIES IN ECOSYSTEM
- TABLE 24 US ADJUSTED RECIPROCAL TARIFF RATES
- TABLE 25 LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
- TABLE 26 LATERAL FLOW ASSAYS MARKET FOR KITS & REAGENTS, BY REGION, 2023-2030 (USD MILLION)
- TABLE 27 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR KITS & REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 28 EUROPE: LATERAL FLOW ASSAYS MARKET FOR KITS & REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 29 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR KITS & REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 30 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR KITS & REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 31 INDICATIVE LIST OF LATERAL FLOW ASSAY KITS & REAGENTS: WITH AND WITHOUT ANALYZERS
- TABLE 32 LATERAL FLOW READERS OFFERED, BY COMPANY
- TABLE 33 LATERAL FLOW ASSAYS MARKET, FOR READERS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 34 LATERAL FLOW ASSAYS MARKET FOR READERS, BY REGION, 2023-2030 (USD MILLION)
- TABLE 35 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR READERS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 36 EUROPE: LATERAL FLOW ASSAYS MARKET FOR READERS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 37 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR READERS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 38 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR READERS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 39 LATERAL FLOW ASSAYS MARKET FOR DIGITAL/HANDHELD READERS, BY REGION, 2023-2030 (USD MILLION)
- TABLE 40 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR DIGITAL/HANDHELD READERS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 41 EUROPE: LATERAL FLOW ASSAYS MARKET FOR DIGITAL/HANDHELD READERS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 42 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR DIGITAL/HANDHELD READERS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 43 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR DIGITAL/HANDHELD READERS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 44 LATERAL FLOW ASSAYS MARKET FOR BENCHTOP READERS, BY REGION, 2023-2030 (USD MILLION)
- TABLE 45 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR BENCHTOP READERS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 46 EUROPE: LATERAL FLOW ASSAYS MARKET FOR BENCHTOP READERS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 47 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR BENCHTOP READERS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 48 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR BENCHTOP READERS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 49 LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
- TABLE 50 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 51 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY REGION, 2023-2030 (USD MILLION)
- TABLE 52 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 53 EUROPE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 54 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 55 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 56 LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2023-2030 (USD MILLION)
- TABLE 57 LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY REGION, 2023-2030 (USD MILLION)
- TABLE 58 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 59 EUROPE: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 60 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 61 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 62 MAJOR PRODUCTS: DENGUE TESTING
- TABLE 63 LATERAL FLOW ASSAYS MARKET FOR MOSQUITO-BORNE DISEASES, BY REGION, 2023-2030 (USD MILLION)
- TABLE 64 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR MOSQUITO-BORNE DISEASES, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 65 EUROPE: LATERAL FLOW ASSAYS MARKET FOR MOSQUITO-BORNE DISEASES, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 66 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR MOSQUITO-BORNE DISEASES, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 67 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR MOSQUITO-BORNE DISEASES, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 68 LATERAL FLOW ASSAYS MARKET FOR INFLUENZA, BY REGION, 2023-2030 (USD MILLION)
- TABLE 69 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR INFLUENZA, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 70 EUROPE: LATERAL FLOW ASSAYS MARKET FOR INFLUENZA, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 71 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR INFLUENZA, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 72 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR INFLUENZA, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 73 LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 74 LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY REGION, 2023-2030 (USD MILLION)
- TABLE 75 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 76 EUROPE: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 77 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 78 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 79 LATERAL FLOW ASSAYS MARKET FOR HIV, BY REGION, 2023-2030 (USD MILLION)
- TABLE 80 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR HIV, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 81 EUROPE: LATERAL FLOW ASSAYS MARKET FOR HIV, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 82 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR HIV, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 83 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR HIV, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 84 LATERAL FLOW ASSAYS MARKET FOR HPV, BY REGION, 2023-2030 (USD MILLION)
- TABLE 85 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR HPV, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 86 EUROPE: LATERAL FLOW ASSAYS MARKET FOR HPV, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 87 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR HPV, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 88 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR HPV, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 89 KEY CHLAMYDIA TESTING PRODUCTS AVAILABLE WORLDWIDE
- TABLE 90 LATERAL FLOW ASSAYS MARKET FOR CHLAMYDIA, BY REGION, 2023-2030 (USD MILLION)
- TABLE 91 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR CHLAMYDIA, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 92 EUROPE: LATERAL FLOW ASSAYS MARKET FOR CHLAMYDIA, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 93 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR CHLAMYDIA, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 94 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR CHLAMYDIA, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 95 LATERAL FLOW ASSAYS MARKET FOR GONORRHEA, BY REGION, 2023-2030 (USD MILLION)
- TABLE 96 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR GONORRHEA, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 97 EUROPE: LATERAL FLOW ASSAYS MARKET FOR GONORRHEA, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 98 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR GONORRHEA, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 99 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR GONORRHEA, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 100 LATERAL FLOW ASSAYS MARKET FOR SYPHILIS, BY REGION, 2023-2030 (USD MILLION)
- TABLE 101 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR SYPHILIS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 102 EUROPE: LATERAL FLOW ASSAYS MARKET FOR SYPHILIS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 103 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR SYPHILIS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 104 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR SYPHILIS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 105 LATERAL FLOW ASSAYS MARKET FOR OTHER SEXUALLY TRANSMITTED INFECTIONS, BY REGION, 2023-2030 (USD MILLION)
- TABLE 106 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR OTHER SEXUALLY TRANSMITTED INFECTIONS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 107 EUROPE: LATERAL FLOW ASSAYS MARKET FOR OTHER SEXUALLY TRANSMITTED INFECTIONS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 108 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR OTHER SEXUALLY TRANSMITTED INFECTIONS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 109 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR OTHER SEXUALLY TRANSMITTED INFECTIONS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 110 LATERAL FLOW ASSAYS MARKET FOR HEPATITIS, BY REGION, 2023-2030 (USD MILLION)
- TABLE 111 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR HEPATITIS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 112 EUROPE: LATERAL FLOW ASSAYS MARKET FOR HEPATITIS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 113 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR HEPATITIS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 114 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR HEPATITIS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 115 GLOBAL NUMBER OF NEWLY DIAGNOSED TB CASES, 2023-2030 (MILLION)
- TABLE 116 LATERAL FLOW ASSAYS MARKET FOR TUBERCULOSIS, BY REGION, 2023-2030 (USD MILLION)
- TABLE 117 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR TUBERCULOSIS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 118 EUROPE: LATERAL FLOW ASSAYS MARKET FOR TUBERCULOSIS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 119 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR TUBERCULOSIS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 120 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR TUBERCULOSIS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 121 LATERAL FLOW ASSAYS MARKET FOR OTHER INFECTIOUS DISEASES, BY REGION, 2023-2030 (USD MILLION)
- TABLE 122 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR OTHER INFECTIOUS DISEASES, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 123 EUROPE: LATERAL FLOW ASSAYS MARKET FOR OTHER INFECTIOUS DISEASES, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 124 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR OTHER INFECTIOUS DISEASES, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 125 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR OTHER INFECTIOUS DISEASES, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 126 LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 127 LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY REGION, 2023-2030 (USD MILLION)
- TABLE 128 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 129 EUROPE: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 130 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 131 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 132 LATERAL FLOW ASSAYS MARKET FOR TROPONIN I & T TESTING, BY REGION, 2023-2030 (USD MILLION)
- TABLE 133 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR TROPONIN I & T TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 134 EUROPE: LATERAL FLOW ASSAYS MARKET FOR TROPONIN I & T TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 135 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR TROPONIN I & T TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 136 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR TROPONIN I & T TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 137 LATERAL FLOW ASSAYS MARKET FOR CK-MB TESTING, BY REGION, 2023-2030 (USD MILLION)
- TABLE 138 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR CK-MB TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 139 EUROPE: LATERAL FLOW ASSAYS MARKET FOR CK-MB TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 140 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR CK-MB TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 141 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR CK-MB TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 142 LATERAL FLOW ASSAYS MARKET FOR BNP & NT-PROBNP TESTING, BY REGION, 2023-2030 (USD MILLION)
- TABLE 143 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR BNP & NT-PROBNP TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 144 EUROPE: LATERAL FLOW ASSAYS MARKET FOR BNP & NT-PROBNP TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 145 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR BNP & NT-PROBNP TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 146 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR BNP & NT-PROBNP TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 147 LATERAL FLOW ASSAYS MARKET FOR MYOGLOBIN TESTING, BY REGION, 2023-2030 (USD MILLION)
- TABLE 148 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR MYOGLOBIN TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 149 EUROPE: LATERAL FLOW ASSAYS MARKET FOR MYOGLOBIN TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 150 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR MYOGLOBIN TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 151 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR MYOGLOBIN TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 152 LATERAL FLOW ASSAYS MARKET FOR D-DIMER TESTING, BY REGION, 2023-2030 (USD MILLION)
- TABLE 153 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR D-DIMER TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 154 EUROPE: LATERAL FLOW ASSAYS MARKET FOR D-DIMER TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 155 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR D-DIMER TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 156 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR D-DIMER TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 157 LATERAL FLOW ASSAYS MARKET FOR OTHER CARDIAC MARKER TESTING, BY REGION, 2023-2030 (USD MILLION)
- TABLE 158 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR OTHER CARDIAC MARKER TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 159 EUROPE: LATERAL FLOW ASSAYS MARKET FOR OTHER CARDIAC MARKER TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 160 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR OTHER CARDIAC MARKER TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 161 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR OTHER CARDIAC MARKER TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 162 LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 163 LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY REGION, 2023-2030 (USD MILLION)
- TABLE 164 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 165 EUROPE: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 166 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 167 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 168 KEY PREGNANCY TESTING PRODUCTS AVAILABLE WORLDWIDE
- TABLE 169 LATERAL FLOW ASSAYS MARKET FOR PREGNANCY TESTING, BY REGION, 2023-2030 (USD MILLION)
- TABLE 170 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 171 EUROPE: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 172 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 173 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 174 LATERAL FLOW ASSAYS MARKET FOR FERTILITY TESTING, BY REGION, 2023-2030 (USD MILLION)
- TABLE 175 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR FERTILITY TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 176 EUROPE: LATERAL FLOW ASSAYS MARKET FOR FERTILITY TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 177 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR FERTILITY TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 178 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR FERTILITY TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 179 KEY CHOLESTEROL TESTING PRODUCTS AVAILABLE WORLDWIDE
- TABLE 180 LATERAL FLOW ASSAYS MARKET FOR CHOLESTEROL/LIPID TESTING, BY REGION, 2023-2030 (USD MILLION)
- TABLE 181 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR CHOLESTEROL/LIPID TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 182 EUROPE: LATERAL FLOW ASSAYS MARKET FOR CHOLESTEROL/LIPID TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 183 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR CHOLESTEROL/LIPID TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 184 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR CHOLESTEROL/LIPID TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 185 LATERAL FLOW ASSAYS MARKET FOR DRUG-OF-ABUSE TESTING, BY REGION, 2023-2030 (USD MILLION)
- TABLE 186 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR DRUG-OF-ABUSE TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 187 EUROPE: LATERAL FLOW ASSAYS MARKET FOR DRUG-OF-ABUSE TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 188 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR DRUG-OF-ABUSE TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 189 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR DRUG-OF-ABUSE TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 190 LATERAL FLOW ASSAYS MARKET FOR OTHER CLINICAL TESTS, BY REGION, 2023-2030 (USD MILLION)
- TABLE 191 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR OTHER CLINICAL TESTS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 192 EUROPE: LATERAL FLOW ASSAYS MARKET FOR OTHER CLINICAL TESTS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 193 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR OTHER CLINICAL TESTS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 194 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR OTHER CLINICAL TESTS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 195 LATERAL FLOW ASSAYS MARKET FOR VETERINARY DIAGNOSTICS, BY REGION, 2023-2030 (USD MILLION)
- TABLE 196 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR VETERINARY DIAGNOSTICS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 197 EUROPE: LATERAL FLOW ASSAYS MARKET FOR VETERINARY DIAGNOSTICS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 198 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR VETERINARY DIAGNOSTICS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 199 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR VETERINARY DIAGNOSTICS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 200 LATERAL FLOW ASSAYS MARKET FOR FOOD & ENVIRONMENT TESTING, BY REGION, 2023-2030 (USD MILLION)
- TABLE 201 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR FOOD & ENVIRONMENT TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 202 EUROPE: LATERAL FLOW ASSAYS MARKET FOR FOOD & ENVIRONMENT TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 203 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR FOOD & ENVIRONMENT TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 204 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR FOOD & ENVIRONMENT TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 205 LATERAL FLOW ASSAYS MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING, BY REGION, 2023-2030 (USD MILLION)
- TABLE 206 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 207 EUROPE: LATERAL FLOW ASSAYS MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 208 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 209 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 210 LATERAL FLOW ASSAYS MARKET, BY TECHNIQUE, 2023-2030 (USD MILLION)
- TABLE 211 LATERAL FLOW ASSAYS MARKET FOR SANDWICH ASSAYS, BY REGION, 2023-2030 (USD MILLION)
- TABLE 212 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR SANDWICH ASSAYS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 213 EUROPE: LATERAL FLOW ASSAYS MARKET FOR SANDWICH ASSAYS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 214 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR SANDWICH ASSAYS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 215 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR SANDWICH ASSAYS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 216 LATERAL FLOW ASSAYS MARKET FOR COMPETITIVE ASSAYS, BY REGION, 2023-2030 (USD MILLION)
- TABLE 217 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR COMPETITIVE ASSAYS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 218 EUROPE: LATERAL FLOW ASSAYS MARKET FOR COMPETITIVE ASSAYS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 219 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR COMPETITIVE ASSAYS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 220 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR COMPETITIVE ASSAYS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 221 LATERAL FLOW ASSAYS MARKET FOR MULTIPLEX DETECTION ASSAYS, BY REGION, 2023-2030 (USD MILLION)
- TABLE 222 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR MULTIPLEX DETECTION ASSAYS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 223 EUROPE: LATERAL FLOW ASSAYS MARKET FOR MULTIPLEX DETECTION ASSAYS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 224 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR MULTIPLEX DETECTION ASSAYS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 225 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR MULTIPLEX DETECTION ASSAYS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 226 LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE, 2023-2030 (USD MILLION)
- TABLE 227 LATERAL FLOW ASSAYS MARKET FOR BLOOD SAMPLES, BY REGION, 2023-2030 (USD MILLION)
- TABLE 228 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR BLOOD SAMPLES, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 229 EUROPE: LATERAL FLOW ASSAYS MARKET FOR BLOOD SAMPLES, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 230 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR BLOOD SAMPLES, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 231 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR BLOOD SAMPLES, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 232 LATERAL FLOW ASSAYS MARKET FOR URINE SAMPLES, BY REGION, 2023-2030 (USD MILLION)
- TABLE 233 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR URINE SAMPLES, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 234 EUROPE: LATERAL FLOW ASSAYS MARKET FOR URINE SAMPLES, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 235 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR URINE SAMPLES, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 236 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR URINE SAMPLES, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 237 LATERAL FLOW ASSAYS MARKET FOR SALIVA SAMPLES, BY REGION, 2023-2030 (USD MILLION)
- TABLE 238 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR SALIVA SAMPLES, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 239 EUROPE: LATERAL FLOW ASSAYS MARKET FOR SALIVA SAMPLES, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 240 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR SALIVA SAMPLES, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 241 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR SALIVA SAMPLES, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 242 LATERAL FLOW ASSAYS MARKET FOR OTHER SAMPLES, BY REGION, 2023-2030 (USD MILLION)
- TABLE 243 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR OTHER SAMPLES, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 244 EUROPE: LATERAL FLOW ASSAYS MARKET FOR OTHER SAMPLES, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 245 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR OTHER SAMPLES, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 246 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR OTHER SAMPLES, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 247 LATERAL FLOW ASSAYS MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 248 LATERAL FLOW ASSAYS MARKET FOR HOSPITALS & CLINICS, BY REGION, 2023-2030 (USD MILLION)
- TABLE 249 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 250 EUROPE: LATERAL FLOW ASSAYS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 251 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 252 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 253 LATERAL FLOW ASSAYS MARKET FOR HOME CARE SETTINGS, BY REGION, 2023-2030 (USD MILLION)
- TABLE 254 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 255 EUROPE: LATERAL FLOW ASSAYS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 256 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 257 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 258 LATERAL FLOW ASSAYS MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, 2023-2030 (USD MILLION)
- TABLE 259 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 260 EUROPE: LATERAL FLOW ASSAYS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 261 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 262 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 263 LATERAL FLOW ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023-2030 (USD MILLION)
- TABLE 264 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 265 EUROPE: LATERAL FLOW ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 266 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 267 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 268 LATERAL FLOW ASSAYS MARKET FOR OTHER END USERS, BY REGION, 2023-2030 (USD MILLION)
- TABLE 269 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR OTHER END USERS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 270 EUROPE: LATERAL FLOW ASSAYS MARKET FOR OTHER END USERS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 271 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR OTHER END USERS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 272 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR OTHER END USERS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 273 LATERAL FLOW ASSAYS MARKET, BY REGION, 2023-2030 (USD MILLION)
- TABLE 274 NORTH AMERICA: MACROECONOMIC INDICATORS
- TABLE 275 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 276 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
- TABLE 277 NORTH AMERICA: LATERAL FLOW READERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 278 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
- TABLE 279 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 280 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2023-2030 (USD MILLION)
- TABLE 281 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 282 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 283 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 284 NORTH AMERICA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2023-2030 (USD MILLION)
- TABLE 285 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2023-2030 (USD MILLION)
- TABLE 286 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 287 US: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
- TABLE 288 US: LATERAL FLOW READERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 289 US: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
- TABLE 290 US: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 291 US: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2023-2030 (USD MILLION)
- TABLE 292 US: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 293 US: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 294 US: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 295 US: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2023-2030 (USD MILLION)
- TABLE 296 US: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2023-2030 (USD MILLION)
- TABLE 297 US: LATERAL FLOW ASSAYS MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 298 CANADA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
- TABLE 299 CANADA: LATERAL FLOW READERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 300 CANADA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
- TABLE 301 CANADA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 302 CANADA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2023-2030 (USD MILLION)
- TABLE 303 CANADA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 304 CANADA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 305 CANADA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 306 CANADA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2023-2030 (USD MILLION)
- TABLE 307 CANADA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2023-2030 (USD MILLION)
- TABLE 308 CANADA: LATERAL FLOW ASSAYS MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 309 EUROPE: MACROECONOMIC INDICATORS
- TABLE 310 EUROPE: LATERAL FLOW ASSAYS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 311 EUROPE: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
- TABLE 312 EUROPE: LATERAL FLOW READERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 313 EUROPE: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
- TABLE 314 EUROPE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 315 EUROPE: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2023-2030 (USD MILLION)
- TABLE 316 EUROPE: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 317 EUROPE: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 318 EUROPE: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 319 EUROPE: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2023-2030 (USD MILLION)
- TABLE 320 EUROPE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2023-2030 (USD MILLION)
- TABLE 321 EUROPE: LATERAL FLOW ASSAYS MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 322 GERMANY: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
- TABLE 323 GERMANY: LATERAL FLOW READERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 324 GERMANY: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
- TABLE 325 GERMANY: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 326 GERMANY: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2023-2030 (USD MILLION)
- TABLE 327 GERMANY: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 328 GERMANY: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 329 GERMANY: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 330 GERMANY: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2023-2030 (USD MILLION)
- TABLE 331 GERMANY: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2023-2030 (USD MILLION)
- TABLE 332 GERMANY: LATERAL FLOW ASSAYS MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 333 UK: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
- TABLE 334 UK: LATERAL FLOW READERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 335 UK: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
- TABLE 336 UK: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 337 UK: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2023-2030 (USD MILLION)
- TABLE 338 UK: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 339 UK: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 340 UK: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 341 UK: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2023-2030 (USD MILLION)
- TABLE 342 UK: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2023-2030 (USD MILLION)
- TABLE 343 UK: LATERAL FLOW ASSAYS MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 344 FRANCE: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
- TABLE 345 FRANCE: LATERAL FLOW READERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 346 FRANCE: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
- TABLE 347 FRANCE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 348 FRANCE: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2023-2030 (USD MILLION)
- TABLE 349 FRANCE: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 350 FRANCE: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 351 FRANCE: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 352 FRANCE: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2023-2030 (USD MILLION)
- TABLE 353 FRANCE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2023-2030 (USD MILLION)
- TABLE 354 FRANCE: LATERAL FLOW ASSAYS MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 355 ITALY: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
- TABLE 356 ITALY: LATERAL FLOW READERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 357 ITALY: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
- TABLE 358 ITALY: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 359 ITALY: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2023-2030 (USD MILLION)
- TABLE 360 ITALY: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 361 ITALY: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 362 ITALY: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 363 ITALY: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2023-2030 (USD MILLION)
- TABLE 364 ITALY: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2023-2030 (USD MILLION)
- TABLE 365 ITALY: LATERAL FLOW ASSAYS MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 366 SPAIN: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
- TABLE 367 SPAIN: LATERAL FLOW READERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 368 SPAIN: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
- TABLE 369 SPAIN: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 370 SPAIN: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2023-2030 (USD MILLION)
- TABLE 371 SPAIN: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 372 SPAIN: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 373 SPAIN: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 374 SPAIN: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2023-2030 (USD MILLION)
- TABLE 375 SPAIN: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2023-2030 (USD MILLION)
- TABLE 376 SPAIN: LATERAL FLOW ASSAYS MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 377 REST OF EUROPE: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
- TABLE 378 REST OF EUROPE: LATERAL FLOW READERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 379 REST OF EUROPE: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
- TABLE 380 REST OF EUROPE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 381 REST OF EUROPE: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2023-2030 (USD MILLION)
- TABLE 382 REST OF EUROPE: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 383 REST OF EUROPE: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 384 REST OF EUROPE: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 385 REST OF EUROPE: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2023-2030 (USD MILLION)
- TABLE 386 REST OF EUROPE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2023-2030 (USD MILLION)
- TABLE 387 REST OF EUROPE: LATERAL FLOW ASSAYS MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 388 ASIA PACIFIC: KEY MACROECONOMIC INDICATORS
- TABLE 389 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 390 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
- TABLE 391 ASIA PACIFIC: LATERAL FLOW READERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 392 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
- TABLE 393 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 394 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2023-2030 (USD MILLION)
- TABLE 395 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 396 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 397 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 398 ASIA PACIFIC: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2023-2030 (USD MILLION)
- TABLE 399 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2023-2030 (USD MILLION)
- TABLE 400 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 401 JAPAN: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
- TABLE 402 JAPAN: LATERAL FLOW READERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 403 JAPAN: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
- TABLE 404 JAPAN: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 405 JAPAN: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2023-2030 (USD MILLION)
- TABLE 406 JAPAN: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 407 JAPAN: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 408 JAPAN: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 409 JAPAN: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2023-2030 (USD MILLION)
- TABLE 410 JAPAN: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2023-2030 (USD MILLION)
- TABLE 411 JAPAN: LATERAL FLOW ASSAYS MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 412 CHINA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
- TABLE 413 CHINA: LATERAL FLOW READERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 414 CHINA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
- TABLE 415 CHINA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 416 CHINA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2023-2030 (USD MILLION)
- TABLE 417 CHINA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 418 CHINA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 419 CHINA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 420 CHINA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2023-2030 (USD MILLION)
- TABLE 421 CHINA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2023-2030 (USD MILLION)
- TABLE 422 CHINA: LATERAL FLOW ASSAYS MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 423 INDIA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
- TABLE 424 INDIA: LATERAL FLOW READERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 425 INDIA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
- TABLE 426 INDIA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 427 INDIA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2023-2030 (USD MILLION)
- TABLE 428 INDIA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 429 INDIA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 430 INDIA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 431 INDIA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2023-2030 (USD MILLION)
- TABLE 432 INDIA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2023-2030 (USD MILLION)
- TABLE 433 INDIA: LATERAL FLOW ASSAYS MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 434 AUSTRALIA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
- TABLE 435 AUSTRALIA: LATERAL FLOW READERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 436 AUSTRALIA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
- TABLE 437 AUSTRALIA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 438 AUSTRALIA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2023-2030 (USD MILLION)
- TABLE 439 AUSTRALIA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 440 AUSTRALIA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 441 AUSTRALIA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 442 AUSTRALIA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2023-2030 (USD MILLION)
- TABLE 443 AUSTRALIA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2023-2030 (USD MILLION)
- TABLE 444 AUSTRALIA: LATERAL FLOW ASSAYS MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 445 SOUTH KOREA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
- TABLE 446 SOUTH KOREA: LATERAL FLOW READERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 447 SOUTH KOREA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
- TABLE 448 SOUTH KOREA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 449 SOUTH KOREA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2023-2030 (USD MILLION)
- TABLE 450 SOUTH KOREA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 451 SOUTH KOREA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 452 SOUTH KOREA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 453 SOUTH KOREA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2023-2030 (USD MILLION)
- TABLE 454 SOUTH KOREA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2023-2030 (USD MILLION)
- TABLE 455 SOUTH KOREA: LATERAL FLOW ASSAYS MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 456 REST OF ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
- TABLE 457 REST OF ASIA PACIFIC: LATERAL FLOW READERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 458 REST OF ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
- TABLE 459 REST OF ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 460 REST OF ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2023-2030 (USD MILLION)
- TABLE 461 REST OF ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 462 REST OF ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 463 REST OF ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 464 REST OF ASIA PACIFIC: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2023-2030 (USD MILLION)
- TABLE 465 REST OF ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2023-2030 (USD MILLION)
- TABLE 466 REST OF ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 467 LATIN AMERICA: KEY MACROECONOMIC INDICATORS
- TABLE 468 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 469 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
- TABLE 470 LATIN AMERICA: LATERAL FLOW READERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 471 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
- TABLE 472 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 473 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2023-2030 (USD MILLION)
- TABLE 474 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 475 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 476 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 477 LATIN AMERICA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2023-2030 (USD MILLION)
- TABLE 478 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2023-2030 (USD MILLION)
- TABLE 479 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 480 BRAZIL: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
- TABLE 481 BRAZIL: LATERAL FLOW READERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 482 BRAZIL: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
- TABLE 483 BRAZIL: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 484 BRAZIL: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2023-2030 (USD MILLION)
- TABLE 485 BRAZIL: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 486 BRAZIL: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 487 BRAZIL: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 488 BRAZIL: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2023-2030 (USD MILLION)
- TABLE 489 BRAZIL: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2023-2030 (USD MILLION)
- TABLE 490 BRAZIL: LATERAL FLOW ASSAYS MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 491 MEXICO: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
- TABLE 492 MEXICO: LATERAL FLOW READERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 493 MEXICO: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
- TABLE 494 MEXICO: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 495 MEXICO: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2023-2030 (USD MILLION)
- TABLE 496 MEXICO: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 497 MEXICO: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 498 MEXICO: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 499 MEXICO: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2023-2030 (USD MILLION)
- TABLE 500 MEXICO: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2023-2030 (USD MILLION)
- TABLE 501 MEXICO: LATERAL FLOW ASSAYS MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 502 ARGENTINA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
- TABLE 503 ARGENTINA: LATERAL FLOW READERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 504 ARGENTINA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
- TABLE 505 ARGENTINA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 506 ARGENTINA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2023-2030 (USD MILLION)
- TABLE 507 ARGENTINA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 508 ARGENTINA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 509 ARGENTINA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 510 ARGENTINA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2023-2030 (USD MILLION)
- TABLE 511 ARGENTINA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2023-2030 (USD MILLION)
- TABLE 512 ARGENTINA: LATERAL FLOW ASSAYS MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 513 REST OF LATIN AMERICA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
- TABLE 514 REST OF LATIN AMERICA: LATERAL FLOW READERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 515 REST OF LATIN AMERICA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
- TABLE 516 REST OF LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 517 REST OF LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2023-2030 (USD MILLION)
- TABLE 518 REST OF LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 519 REST OF LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 520 REST OF LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 521 REST OF LATIN AMERICA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2023-2030 (USD MILLION)
- TABLE 522 REST OF LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2023-2030 (USD MILLION)
- TABLE 523 REST OF LATIN AMERICA: LATERAL FLOW ASSAYS MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 524 MIDDLE EAST & AFRICA: KEY MACROECONOMIC INDICATORS
- TABLE 525 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
- TABLE 526 MIDDLE EAST & AFRICA: LATERAL FLOW READERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 527 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
- TABLE 528 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 529 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2023-2030 (USD MILLION)
- TABLE 530 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 531 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 532 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 533 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2023-2030 (USD MILLION)
- TABLE 534 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2023-2030 (USD MILLION)
- TABLE 535 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 536 GCC COUNTRIES: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
- TABLE 537 GCC COUNTRIES: LATERAL FLOW READERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 538 GCC COUNTRIES: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
- TABLE 539 GCC COUNTRIES: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 540 GCC COUNTRIES: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2023-2030 (USD MILLION)
- TABLE 541 GCC COUNTRIES: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 542 GCC COUNTRIES: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 543 GCC COUNTRIES: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 544 GCC COUNTRIES: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2023-2030 (USD MILLION)
- TABLE 545 GCC COUNTRIES: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2023-2030 (USD MILLION)
- TABLE 546 GCC COUNTRIES: LATERAL FLOW ASSAYS MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 547 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN LATERAL FLOW ASSAYS MARKET
- TABLE 548 LATERAL FLOW ASSAYS MARKET: DEGREE OF COMPETITION
- TABLE 549 LATERAL FLOW ASSAYS MARKET: REGIONAL FOOTPRINT, 2024
- TABLE 550 LATERAL FLOW ASSAYS MARKET: PRODUCT FOOTPRINT, 2024
- TABLE 551 LATERAL FLOW ASSAYS MARKET: TECHNIQUE FOOTPRINT. 2024
- TABLE 552 LATERAL FLOW ASSAYS MARKET: APPLICATION FOOTPRINT, 2024
- TABLE 553 LATERAL FLOW ASSAYS MARKET: SAMPLE TYPE FOOTPRINT, 2024
- TABLE 554 LATERAL FLOW ASSAYS MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS, 2024
- TABLE 555 LATERAL FLOW ASSAYS MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES, 2024
- TABLE 556 LATERAL FLOW ASSAYS MARKET: PRODUCT LAUNCHES, JANUARY 2021-MAY 2025
- TABLE 557 LATERAL FLOW ASSAYS MARKET: DEALS, JANUARY 2021-MAY 2025
- TABLE 558 LATERAL FLOW ASSAYS MARKET: EXPANSIONS, JANUARY 2021-MAY 2025
- TABLE 559 ABBOTT LABORATORIES: BUSINESS OVERVIEW
- TABLE 560 ABBOTT LABORATORIES: PRODUCTS OFFERED
- TABLE 561 ABBOTT LABORATORIES: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-MAY 2025
- TABLE 562 F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW
- TABLE 563 F. HOFFMANN-LA ROCHE LTD.: PRODUCTS OFFERED
- TABLE 564 DANAHER CORPORATION: COMPANY OVERVIEW
- TABLE 565 DANAHER CORPORATION: PRODUCTS OFFERED
- TABLE 566 QUIDELORTHOORTHO CORPORATION: COMPANY OVERVIEW
- TABLE 567 QUIDELORTHOORTHO CORPORATION: PRODUCTS OFFERED
- TABLE 568 QUIDELORTHOORTHO CORPORATION: DEALS
- TABLE 569 SIEMENS AG: COMPANY OVERVIEW
- TABLE 570 SIEMENS AG: PRODUCTS OFFERED
- TABLE 571 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW
- TABLE 572 BECTON, DICKINSON AND COMPANY: PRODUCTS OFFERED
- TABLE 573 BIOMERIEUX SA: COMPANY OVERVIEW
- TABLE 574 BIOMERIEUX SA: PRODUCTS OFFERED
- TABLE 575 BIOMERIEUX SA: DEALS
- TABLE 576 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
- TABLE 577 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED
- TABLE 578 REVVITY, INC.: COMPANY OVERVIEW
- TABLE 579 REVVITY, INC.: PRODUCTS OFFERED
- TABLE 580 QIAGEN N.V.: COMPANY OVERVIEW
- TABLE 581 QIAGEN N.V.: PRODUCTS OFFERED
- TABLE 582 MERCK KGAA: COMPANY OVERVIEW
- TABLE 583 MERCK KGAA: PRODUCTS OFFERED
- TABLE 584 MERCK KGAA: EXPANSIONS
- TABLE 585 HOLOGIC, INC.: COMPANY OVERVIEW
- TABLE 586 HOLOGIC, INC.: PRODUCTS OFFERED
- TABLE 587 HOLOGIC, INC.: DEALS
- TABLE 588 SURMODICS, INC.: COMPANY OVERVIEW
- TABLE 589 SURMODICS, INC.: PRODUCTS OFFERED
- TABLE 590 SURMODICS, INC.: DEALS
- TABLE 591 ORASURE TECHNOLOGIES: COMPANY OVERVIEW
- TABLE 592 ORASURE TECHNOLOGIES: PRODUCTS OFFERED
- TABLE 593 CHEMBIO DIAGNOSTICS INC.: COMPANY OVERVIEW
- TABLE 594 DCN DIAGNOSTICS: COMPANY OVERVIEW
- TABLE 595 POLYSCIENCES INC.: COMPANY OVERVIEW
- TABLE 596 ABINGDON HEALTH: COMPANY OVERVIEW
- TABLE 597 ORANOXIS INC.: COMPANY OVERVIEW
- TABLE 598 AESKU.GROUP GMBH: COMPANY OVERVIEW
- TABLE 599 BIO GROUP MEDICAL SYSTEM S.R.L: COMPANY OVERVIEW
- TABLE 600 PHARMACT GMBH: COMPANY OVERVIEW
- TABLE 601 XIAMEN BIOTIME BIOTECHNOLOGY CO., LTD.: COMPANY OVERVIEW
- TABLE 602 BIOPANDA REAGENTS LTD: COMPANY OVERVIEW
- TABLE 603 ARTRON LABORATORIES INC.: COMPANY OVERVIEW
List of Figures
- FIGURE 1 LATERAL FLOW ASSAYS: MARKET SEGMENTATION
- FIGURE 2 STUDY YEARS CONSIDERED
- FIGURE 3 LATERAL FLOW ASSAYS MARKET: RESEARCH DESIGN
- FIGURE 4 KEY DATA FROM SECONDARY SOURCES
- FIGURE 5 LIST OF PRIMARY SOURCES
- FIGURE 6 KEY INSIGHTS FROM INDUSTRY EXPERTS
- FIGURE 7 BREAKDOWN OF PRIMARY INTERVIEWS, BY COMPANY TYPE, DESIGNATION, AND REGION
- FIGURE 8 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH
- FIGURE 9 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
- FIGURE 10 LATERAL FLOW ASSAYS MARKET: TOP-DOWN APPROACH
- FIGURE 11 DATA TRIANGULATION METHODOLOGY
- FIGURE 12 LATERAL FLOW ASSAYS MARKET: ASSUMPTION IMPACT ASSESSMENT
- FIGURE 13 LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2025 VS. 2030 (USD BILLION)
- FIGURE 14 LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION)
- FIGURE 15 LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2025 VS. 2030 (USD MILLION)
- FIGURE 16 LATERAL FLOW ASSAY MARKET, BY SAMPLE TYPE, 2025 VS. 2030 (USD MILLION)
- FIGURE 17 LATERAL FLOW ASSAYS MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
- FIGURE 18 GEOGRAPHICAL SNAPSHOT OF LATERAL FLOW ASSAYS MARKET
- FIGURE 19 HIGH PREVALENCE OF INFECTIOUS DISEASES TO DRIVE MARKET
- FIGURE 20 CLINICAL TESTING APPLICATION AND CHINA LED ASIA PACIFIC MARKET IN 2024
- FIGURE 21 CHINA TO RECORD HIGHEST GROWTH RATE FROM 2025 TO 2030
- FIGURE 22 ASIA PACIFIC TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD
- FIGURE 23 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD
- FIGURE 24 LATERAL FLOW ASSAYS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
- FIGURE 25 LATERAL FLOW ASSAYS MARKET: PORTER'S FIVE FORCES ANALYSIS
- FIGURE 26 LATERAL FLOW ASSAYS MARKET: PATENT ANALYSIS, JANUARY 2015-DECEMBER 2024
- FIGURE 27 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS
- FIGURE 28 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS
- FIGURE 29 VALUE CHAIN ANALYSIS: MAJOR VALUE-ADDED DURING MANUFACTURING AND ASSEMBLY PHASES
- FIGURE 30 LATERAL FLOW ASSAYS MARKET: SUPPLY CHAIN ANALYSIS
- FIGURE 31 AI USE CASES
- FIGURE 32 LATERAL FLOW ASSAYS MARKET: ECOSYSTEM ANALYSIS
- FIGURE 33 ADJACENT MARKETS FOR LATERAL FLOW ASSAYS MARKET
- FIGURE 34 LATERAL FLOW ASSAYS MARKET: TRENDS AND DISRUPTIONS IMPACTING CUSTOMER BUSINESS
- FIGURE 35 LATERAL FLOW ASSAYS MARKET: INVESTMENT AND FUNDING SCENARIO, 2020-2024
- FIGURE 36 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET SNAPSHOT
- FIGURE 37 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET SNAPSHOT
- FIGURE 38 REVENUE ANALYSIS OF KEY PLAYERS IN LATERAL FLOW ASSAYS MARKET, 2020-2024
- FIGURE 39 MARKET SHARE ANALYSIS OF KEY PLAYERS IN LATERAL FLOW ASSAYS MARKET, 2024
- FIGURE 40 EV/EBITDA OF KEY VENDORS, 2025
- FIGURE 41 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS, 2025
- FIGURE 42 LATERAL FLOW ASSAYS MARKET: BRAND/PRODUCT COMPARISON
- FIGURE 43 LATERAL FLOW ASSAYS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
- FIGURE 44 LATERAL FLOW ASSAYS MARKET: COMPANY FOOTPRINT, 2024
- FIGURE 45 LATERAL FLOW ASSAYS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
- FIGURE 46 ABBOTT LABORATORIES: COMPANY SNAPSHOT, 2024
- FIGURE 47 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT, 2024
- FIGURE 48 DANAHER CORPORATION: COMPANY SNAPSHOT, 2024
- FIGURE 49 QUIDELORTHOORTHO CORPORATION: COMPANY SNAPSHOT, 2024
- FIGURE 50 SIEMENS AG: COMPANY SNAPSHOT, 2024
- FIGURE 51 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT, 2024
- FIGURE 52 BIOMERIEUX SA: COMPANY SNAPSHOT, 2024
- FIGURE 53 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT, 2024
- FIGURE 54 REVVITY, INC.: COMPANY SNAPSHOT, 2024
- FIGURE 55 QIAGEN N.V.: COMPANY SNAPSHOT, 2024
- FIGURE 56 MERCK KGAA: COMPANY SNAPSHOT, 2024
- FIGURE 57 HOLOGIC, INC.: COMPANY SNAPSHOT, 2024
- FIGURE 58 SURMODICS, INC.: COMPANY SNAPSHOT, 2024
- FIGURE 59 ORASURE TECHNOLOGIES: COMPANY SNAPSHOT, 2024
02-2729-4219
+886-2-2729-4219
美國橫向流動化驗市場規模、佔有率、趨勢分析報告：按產品、應用、技術、最終用途、細分市場預測，2025-2033
日本側向層析檢測市場報告（按技術、產品、應用、最終用戶和地區）2025-2033橫向流動化驗市場規模、佔有率、趨勢分析報告：按產品、方法、最終用途、測試、最終用途、地區、細分市場預測，2025-2030 年
全球橫向流動化驗市場：依產品類型、應用、技術、最終用戶、地區分類的規模與趨勢、COVID-19 影響分析、2030 年預測
2025年橫向流動化驗全球市場報告
橫向流動化驗市場：依產品類型、方法、應用、最終用戶和地區分類側流化驗的全球市場:市場規模·佔有率·趨勢，產業分析 (各用途·實驗類別·各最終用途·各地區)，未來預測 (2025年～2034年)
全球橫向流動分析市場：特色見解（2025-2030年）
橫向流動化驗市場規模、佔有率、成長分析、按產品類型、按方法、按樣本類型、按應用、按最終用戶、按地區行業預測，2024-2031 年
橫向流動化驗市場組件：按類型、技術、應用和最終用途分類 - 2025-2030 年全球預測
▼